Recruiting NA INTERVENTIONAL 1-arm NCT05961982

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study (ERASE)

Endoscopic Ultrasound-Guided Radiofrequency Ablation of Pancreatic Cysts - A Safety and Efficacy Trial (ERASE Study)

Sponsor: Ohio State University Comprehensive Cancer Center

Interventions Chemical Ablation Computed Tomography Electronic Health Record Review Endoscopic Ultrasound-Guided Fine-Needle Aspiration Endoscopic Ultrasound-Guided Radiofrequency Ablation Magnetic Resonance Cholangiopancreatography Magnetic Resonance Imaging

Updated 4 times since 2023 Last updated: Mar 3, 2025 Started: Apr 24, 2023 Primary completion: Dec 31, 2026 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Pancreatic Neoplasm, this trial is actively recruiting participants. The trial is conducted by Ohio State University Comprehensive Cancer Center and has accumulated 4 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Apr 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Apr 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Aug 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Apr 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ohio State University Comprehensive Cancer Center

Data source: Ohio State University Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Columbus, United States